Abstract |
A series of novel group I metabotropic glutamate receptor (mGlu) antagonists have been designed on the basis of the 4-carboxyphenylglycine pharmacophore. The compounds are either mGlu1 receptor selective or equipotent for both mGlu1 and mGlu5 receptors and have IC(50) values ranging from 1 to 30 microM determined by phosphoinositide hydrolysis (PI) assay in vitro. All the compounds produced dose-dependent inhibition of group I mGlu receptor agonist (RS)-3,5-dihydroxyphenylglycine (DHPG)-induced limbic seizure responses in mice with ED(50) values ranging from 9 nmol for LY393053 to 138 nmol for LY339840 after intracerebroventricular injection and were more potent than the mGlu1 receptor antagonist 1-aminoindan-1,5-dicarboxylic acid (ED(50)=477 nmol). Further antagonist actions were also demonstrated in a model of (RS)-DHPG-induced PI hydrolysis in vivo such that LY367385 and the active cis isomer of LY393053 produced dose-dependent inhibition of PI responses in both cerebellum and hippocampus. Cis LY393053 also inhibited hippocampal PI responses when administered intraperitoneally at a dose of 30 mg/kg. These compounds define a new series of group I mGlu receptor antagonists which may serve as useful experimental tools.
|
Authors | Ann E Kingston, Kelly Griffey, Michael P Johnson, Mary-Jo Chamberlain, Gerald Kelly, Rosemarie Tomlinson, Rebecca A Wright, Bryan G Johnson, Darryle D Schoepp, John R Harris, Barry P Clark, Richard S Baker, Joseph T Tizzano |
Journal | Neuroscience letters
(Neurosci Lett)
Vol. 330
Issue 2
Pg. 127-30
(Sep 20 2002)
ISSN: 0304-3940 [Print] Ireland |
PMID | 12231428
(Publication Type: Journal Article)
|
Chemical References |
- 2-amino-2-(3-carboxycyclobutyl)-3-(9H-xanthen-9-yl)propionic acid
- 2-amino-2-(4-carboxyphenyl)-3-(9H-xanthen-9-yl)propanoic acid
- 2-methyl-3-hydroxy-4-carboxyphenylglycine
- Benzoates
- Excitatory Amino Acid Agonists
- Excitatory Amino Acid Antagonists
- LY393053
- Propionates
- Receptors, Metabotropic Glutamate
- Resorcinols
- Thiophenes
- Xanthenes
- alpha-thioxantylmethyl-4-carboxyphenylglycine
- carboxyphenylglycine
- metabotropic glutamate receptor type 1
- alpha-methyl-4-carboxyphenylglycine
- 3,5-dihydroxyphenylglycine
- Alanine
- Glycine
|
Topics |
- Alanine
(analogs & derivatives, pharmacology)
- Animals
- Benzoates
(pharmacology)
- Cerebellum
(drug effects, metabolism)
- Dose-Response Relationship, Drug
- Drug Interactions
- Excitatory Amino Acid Agonists
(pharmacology)
- Excitatory Amino Acid Antagonists
(pharmacology)
- Glycine
(analogs & derivatives, chemistry, pharmacology)
- Hippocampus
(drug effects, metabolism)
- Inhibitory Concentration 50
- Mice
- Propionates
(pharmacology)
- Rats
- Rats, Sprague-Dawley
- Receptors, Metabotropic Glutamate
(agonists, antagonists & inhibitors, metabolism)
- Resorcinols
(pharmacology)
- Seizures
(prevention & control)
- Structure-Activity Relationship
- Thiophenes
(pharmacology)
- Xanthenes
(pharmacology)
|